Your search matched 58 results
Ernest Quintana knew he had long suffered from a deadly lung disease when he was rushed to the hospital, but the news of his imminent death still profoundly shocked him and his family—not because of its grimness but who delivered it: a robot.
GlaxoSmithKline announced that it will acquire Waltham, Massachusetts-based drug company Tesaro, which develops novel cancer treatments, for $5.1 billion cash.
With funding from Google, Stanford, and venture capital giants Sequoia and Andreessen Horowitz, seven-year-old Zipline has already revolutionized health care in Rwanda.
Amazon Web Services (AWS) has unveiled new machine-learning tools reflecting—and beginning to tackle—some of the greatest challenges facing modern medicine.
Nonprofit hospital system Partners HealthCare has unveiled a joint venture with Circulation, an on-demand rideshare service, through which Medicare patients receive free rides to their doctor’s offices in non-emergencies.
Helping modernize the clinical trials process by leaps and bounds, Janssen is undertaking new initiatives to empower research volunteers.
The growing appeal of orphan drugs to manufacturers isn’t a groundbreaking story, but a new report identifies some head-spinning facts behind the focal shift from blockbuster to rare-disease drugs.
Complications from drug interactions can present patients with whole new afflictions.
A landmark approval by the FDA will put the first marijuana-derived prescription drug behind pharmacy counters this fall.
The State Supreme Court just resolved a 10-year battle between the Cleveland Clinic and a former patient, retired U.S.
Beginning with its acquisition of PillPack, Amazon’s grand entrance into healthcare continues with its partnership with J.P.
Digital health company Peerwell created an app to prepare patients for surgery and, in turn, reduce the amount of time they spend in the hospital.
A new Deloitte report explores the near-future of blockchain: how seriously the world’s top executives, including many in healthcare, regard the emerging technology and how soon they might invest in it.
Holistic healthcare brand Otsuka Pharmaceutical has announced a promising partnership with Science 37, the trailblazing startup out of MIT that’s transforming clinical trials for everyone.
To retail behemoths, the health care realm is growing irresistible.
Advantia Health, a leading-edge medical company committed to empowering women with integrated health care services, announced a new partnership with Elligo Health Research, which will offer Advantia’s clients access to a whole new realm of resources, through clinical trials.
Forecasting next year’s biggest shifts within the healthcare landscape, Syneos Health has released 2019 Health Trend Ten, available for download now, which explicates ten of the trends that will redefine healthcare globally.
Pharmaceutical giant Roche’s new app for people with multiple sclerosis (MS) revolutionizes how doctors care for patients with the disease.
A recent proposal by the U.S.
Pfizer and Novartis have been independently developing therapies for nonalcoholic steatohepatitis (NASH), and they’re now set to join forces to yield a combination therapy for the fatty liver disease linked closely with metabolic disorders.
After taking some major leaps into healthcare, Google has begun solidifying its foothold in the space by appointing Dr.
Recognizing that the impact of multiple sclerosis (MS) goes beyond the conventionally recognized symptoms, Sanofi has announced a new app to support people with the disease—specifically, their mental health.
In a telling new study, pre- and post-surgical efforts by pharmacists yielded staggering effects on patient opioid use.
In the first half of this new year, the United States FDA will incentivize many pharmaceutical brands to make their biggest prescription drugs available over the counter.
Digital therapeutics, or DTx, are distinct from digital health products, and are driven by software programs that can be prescribed to prevent, manage, or treat a medical disorder or disease, as stated by the Digital Therapeutics Alliance.
In a new Harvard Business Review article, brand positioning expert Denise Lee Yohn distills some of the most useful marketing points gleaned from her 25 years of marketing leadership.
In some rooms at Cedars-Sinai Hospital, patients won’t spend a moment alone—sort of—now that the leading Beverly Hills medical center has partnered with Aiva Health to make select rooms smart.
Responding to rampant criticism of rising drug prices, pharma giant Eli Lilly will begin selling an authorized generic of its preeminent insulin therapy, Humalog, at half-price.
Where will digital therapeutics or DTx be in five years?